AFP
SURF

Ausdal Financial Partners’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Ausdal Financial Partners’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$76K – 524
2021
Q3 		$76K Hold
10,000
– – 0.01% 463
2021
Q2 		$75K Hold
10,000
– – 0.01% 454
2021
Q1 		$78K Buy
+10,000
New +$100K 0.01% 437

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ausdal Financial Partners's SURF Position: Q4 2021 in Review

Ausdal Financial Partners sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2021, closing a stake of 10,000 shares — an estimated $76K sold.

Ausdal Financial Partners first reported a position in SURF in Q1 2021 and held it in 3 quarters. The position peaked at $78K in Q1 2021. 106 funds tracked by Wall St. Rank hold SURF as of Q4 2021.

  • Ausdal Financial Partners reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Ausdal Financial Partners sold 10,000 Surface Oncology, Inc. Common Stock shares in Q4 2021, an estimated $76K.
  • Ausdal Financial Partners first reported a position in Surface Oncology, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Ausdal Financial Partners's Surface Oncology, Inc. Common Stock position peaked at $78K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2021.

Based on Ausdal Financial Partners's 13F filing for Q4 2021, filed 8 Feb 2022.